The compound effectively modulated ASNS expression and induced programmed cell death (apoptosis) in cancer cells, suggesting its potential as a therapeutic strategy in overcoming asparaginase resistance and selectively targeting cancer cells [15]. Here, ASPG is linked to cancer.